drugset / Trial / NCT07366372
Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aimed to assess effectiveness of a taurolidine based lock solution in preventing the infections of central venous catheter (CVC) in intensive care unit (ICU) cases.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tigecycline | Small molecule | 5 mg/ml | Other |
| Subject | taurolidine | Small molecule | 1.35 % | Other |
| Background | Heparin | Other / unclassified | 500 iu | Other |
| Background | citrate | Unknown | 4 % | Other |
Indications
No indication recorded.